Affinity Technologies, Inc. today released a study of a complex clinical case in which CyPath® Lung's real-time assessment of the lung microenvironment identified a hidden recurrence of breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback